GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti.

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare costs. Lifestyle changes and improved diets are critical but often ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

EXPERTS have revealed there could be a ‘golden dose’ of Mounjaro that helps shift the most weight – and it’s not the highest one. Weight loss jab users tend to start on lowe… ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for my updated look at REGN.

Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.

The FTC Has the Chance to Rein in Big Pharma Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.

The 2.5mg vial is available at $399 per month. Lilly claims the single-dose versions cost at least 50% less than the list price of other incretin medicines for obesity.

Thimerosal has been a target of groups that question vaccine safety. What vaccines still contain the mercury compound, and what would happen if the recommendations against its use become official?